Listy 117, 106111
Human clinical trial data remains sparse, and the compound shares much of BPC-157's regulatory history: popular before 2023, restricted under Biden-era FDA action, and now under consideration for reinstatement
Researchers should consult ClinicalTrials.gov and the primary literature for the latest status of each arm
No, seizures are not listed as a known adverse effect in FDA prescribing information for semaglutide (Wegovy, Ozempic) or other GLP-1 receptor agonists
Discontinuation & Withdrawal Heres the not-so-fun plot twist: stopping Ativan suddenly can trigger not just anxiety, but full-body withdrawalseizures, confusion, even death in rare cases
She had paid cash, to a clinician who kept a selection of off-market peptides bought from a Chinese manufacturer